Thomas Deuel

Thomas Deuel

President chez
Edward R. Mallinckrodt Foundation
91 ans
Consumer Services
Health Technology
Commercial Services

Profil

Dr. Thomas F.
Deuel
, MD, is Independent Director at Enzon Pharmaceuticals, Inc., a Director-Vascular Biology Affinity Group at The Scripps Research Institute, a Professor-Emeritus at Harvard Medical School, President at Edward R.
Mallinckrodt Foundation, and a Member at Institute of Medicine.
He is on the Board of Directors at Enzon Pharmaceuticals, Inc. Dr. Deuel also served on the board at ImClone Systems, Inc. and Beth Israel Hospital.
Dr. Deuel received his undergraduate degree from Princeton University and a doctorate degree from Columbia University.

Postes actifs de Thomas Deuel

SociétésPosteDébut
Corporate Officer/Principal 01/02/2002
Edward R. Mallinckrodt Foundation
President -
Corporate Officer/Principal 01/01/1998
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Thomas Deuel

SociétésPosteFin
Directeur/Membre du Conseil 22/10/2013
Directeur/Membre du Conseil 24/11/2008
Corporate Officer/Principal 01/01/2002
Voir l'expérience en détail de Thomas Deuel

Formation de Thomas Deuel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Edward R. Mallinckrodt Foundation

Consumer Services

  1. Bourse
  2. Insiders
  3. Thomas Deuel